Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia

NCT00654576 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1400

Last updated 2008-04-08

No results posted yet for this study

Summary

Antipsychotic alone is limit to improve the overall outcome of schizophrenia and has a high discontinue rate.To solve these problems, we provide practical and available psychosocial intervention. We hypothesize that there will be significant difference in the overall effectiveness between antipsychotic and antipsychotic combination with psychosocial intervention.

Conditions

Interventions

DRUG

Chlorpromazine, Sulpiride, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripitrazole

patient will receive one of the seven study drugs (Chlorpromazine, Sulpiride, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripitrazole) as the maintain treatment. the dose is flexible, is based on the study doctor's judgment.

BEHAVIORAL

psychosocial intervention

the psychosocial interventions include psychoeducaiton, family intervention, skill training, and cognitive-behavioral therapy.

Sponsors & Collaborators

  • Shanghai Mental Health Center

    collaborator OTHER
  • Sichuan University

    collaborator OTHER
  • Capital Medical University

    collaborator OTHER
  • Nanjing Medical University

    collaborator OTHER
  • Jiangxi Mental Hospital

    collaborator UNKNOWN
  • Hunan Mental Hospital

    collaborator OTHER
  • Guangzhou Mental Hospital

    collaborator OTHER
  • Chongqing Metal Institute

    collaborator UNKNOWN
  • Henan Mental Hospital

    collaborator UNKNOWN
  • Central South University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00654576 on ClinicalTrials.gov